MTMR14 depletion aggravates intrapulmonary inflammation and emphysema in experimental COPD through activating

Jiaheng Zhang1, Yuan Zhan2, Zhesong Deng1

  • 1Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.

Respiratory Research
|July 10, 2025
PubMed
Abstract

Insights

Myotubularin-related protein 14 (MTMR14) mitigates pro-inflammatory macrophage polarization in chronic obstructive pulmonary disease (COPD). Lower MTMR14 levels worsen COPD symptoms and emphysema, highlighting its therapeutic potential.

Area of Science:

  • Pulmonary medicine
  • Immunology
  • Cell biology

Background:

  • Chronic obstructive pulmonary disease (COPD) involves airway inflammation and emphysema, with macrophage polarization playing a key role.
  • Myotubularin-related protein 14 (MTMR14) expression is decreased in COPD, particularly in alveolar macrophages, necessitating further investigation into its function.
  • Prior studies indicated MTMR14's role in COPD progression, prompting this research into its specific mechanisms within macrophages.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of MTMR14 in macrophages relevant to COPD pathogenesis.
  • To elucidate how MTMR14 influences macrophage polarization and inflammatory responses in the context of COPD.
  • To identify potential therapeutic targets for COPD based on MTMR14's function.

Main Methods:

  • Bioinformatic analysis, clinical detection, and in vivo/vitro experiments were employed to study MTMR14 in COPD macrophages.
  • Animal models with Mtmr14 knockout and cell models with MTMR14 knockdown/overexpression were used to assess its functional impact.
  • Signaling pathways (PI3K/Akt, NF-κB), macrophage-epithelium crosstalk, and ubiquitin-proteasome system regulation of MTMR14 were investigated.

Main Results:

  • MTMR14 was found to be downregulated in macrophages of COPD patients, confirmed across various models.
  • MTMR14 knockout exacerbated pulmonary dysfunction, emphysema, and M1 macrophage polarization in a mouse model of COPD.
  • MTMR14 negatively regulated M1 polarization via PI3K/Akt and NF-κB pathways, and TRIM21 was identified as a negative regulator of MTMR14 via the ubiquitin-proteasome system.

Conclusions:

  • MTMR14 plays a crucial role in mitigating the polarization of macrophages towards a pro-inflammatory phenotype in COPD.
  • Downregulation of MTMR14 contributes to emphysema progression and alveolar epithelial damage.
  • MTMR14 represents a promising therapeutic target for the prevention and intervention of COPD.